LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
WASHINGTON - The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the company's marketing of the epilepsy drug Neurontin.
TEL AVIV - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities (NTEs) could generate revenue of $1 billion to $1.5 billion by 2018.
- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration agreed to review the results of a failed mid-stage trial of a painkiller made with the company's technology designed to deter abuse.
- Boston Scientific Corp's anti-stroke device did not meet one measure of success in a clinical study of the implant, but other data must be considered when determining overall safety and effectiveness, staff members of the U.S. Food and Drug Administration stressed on Monday.
- United Therapeutics Corp said it received a subpoena from the U.S. Department of Health and Human Services regarding marketing practices used to sell three of its drugs to treat pulmonary arterial hypertension (PAH).
NEW YORK (Reuters Health) - Violent movie characters often engage in other risky behaviors like sex and drinking, according to a new study. Those compounded behaviors also occur equally among PG-13 and R-rated movies.
- A closely watched leukemia drug developed by Johnson & Johnson and Pharmacyclics Inc maintained its effectiveness in keeping the disease at bay for most patients, according to long-term follow-up data from a midstage study being presented at a major medical meeting.
ZURICH - Swiss drugmaker Novartis said on Monday it had started supplying its meningitis B vaccine to Princeton University in an effort to stop an outbreak of meningitis on the Ivy League campus.
- An experimental AbbVie Inc drug for leukemia controlled or eliminated signs of the disease in more than 80 percent of patients who had failed to benefit from previous treatments, an unprecedented finding that could spur use of the medicine for other cancers, researchers said.
ORLANDO, Florida - A Florida researcher is preparing to test massive dust storms in the upper atmosphere that roll in from Africa to see whether pathogens raining down on the state could be responsible for plant, animal or human disease.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage